AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRIPLE POINT INCOME VCT PLC

Declaration of Voting Results & Voting Rights Announcements Jul 31, 2020

4875_rns_2020-07-31_5c92f9f9-22af-4b29-b67f-5db2c92fdf81.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8379U

Triple Point Inc VCT - TPVE

31 July 2020

31 July 2020

Triple Point Income VCT plc

(the "Company")

TRANSACTION IN OWN SHARES

The Board of Triple Point Income VCT plc announces that on 31 July 2020, it purchased for cancellation 96,999 D Ordinary Shares of 1p each in the capital of the Company ("D Shares") at a price of 52.23p per D Share.

Total Voting Rights

Following the transaction, the issued share capital of the Company is as follows:

13,441,438 C Ordinary Shares

13,604,637 D Ordinary Shares

28,949,575 E Ordinary Shares

The Company does not hold any shares in Treasury. Accordingly, the total number of voting rights in the Company is 55,995,650. This figure may be used by shareholders as the denominator for the purposes of calculating whether or not they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

Triple Point Investment Management LLP

(Investment Manager)
Tel: 020 7201 8989
Ben Beaton

Belinda Thomas

The Company's LEI is 213800IXD8S5WY88L245.

Further information on the Company can be found on its website https://www.triplepoint.co.uk/current-vcts/triple-point-income-vct-plc/s1238/.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

POSFLFLRDEILVII

Talk to a Data Expert

Have a question? We'll get back to you promptly.